Craft
Abingworth

Abingworth

Revenue

£14.7 M

FY, 2018

Abingworth Summary

Company summary

Overview
Abingworth is an international bioscience investment firm that invests in seed stage projects, technology platforms, preclinical and clinical assets, and approved and marketed products. Its venture funds are focused on strategic areas of venture capital, clinical co-development, venture investments in public equities (VIPEs), and public markets. The firm supports companies at all stages of development, from start-ups to publicly traded companies, across all life sciences sectors, including biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, technologies, medical devices, diagnostics, and instrumentation.
Type
Investor
Founded
1973
HQ
London, GB | view all locations
Website
http://www.abingworth.com/
Cybersecurity rating
Sectors

Key people

  • Tim Haines, Chairman & Managing Partner

  • Kurt von Emster, Managing Partner

  • Genghis Lloyd-Harris, Managing Partner

  • Vincent Miles

LocationsView all

3 locations detected

  • London, England HQ

    United Kingdom

    33 Jermyn St, St. James's

  • Boston, MA

    United States

    420 Boylston St #501

  • Menlo Park, CA

    United States

    3000 Sand Hill Rd

Abingworth Financials

Summary financials

Revenue (FY, 2018)
£14.7M
Net income (FY, 2018)
£4.8M
Cash (FY, 2018)
£5.1M
EBIT (FY, 2018)
£5.0M

Footer menu